Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round

N/A

Acquisition
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
INR2021202220232024202520262027
Revenues0000000000000000000000000000
% growth3 %16 %13 %10 %9 %10 %10 %
EBITDA0000000000000000000000000000
% EBITDA margin27 %30 %28 %30 %33 %28 %29 %
Profit0000000000000000000000000000
% profit margin9 %9 %20 %20 %21 %22 %23 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo
Investments analysisEdit

Investments by Sun Pharmaceutical Industries

Edit
DUSA Pharmaceuticals
ACQUISITION by Sun Pharmaceutical Industries Nov 2012
InSite Vision
ACQUISITION by Sun Pharmaceutical Industries Sep 2015
Concert Pharmaceuticals
ACQUISITION by Sun Pharmaceutical Industries Jan 2023
Ranbaxy Laboratories
ACQUISITION by Sun Pharmaceutical Industries Apr 2014
OJSC Biosintez
ACQUISITION by Sun Pharmaceutical Industries Nov 2016
View 9 more